Related Experiment Video
Updated: May 23, 2026
07:58
Induction and Assessment of Ischemia-reperfusion Injury in Langendorff-perfused Rat Hearts
Published on: July 27, 2015
Pharmacological approaches to reperfusion therapy
Olivier Morel1, Thibault Perret, Nicolas Delarche
1Pôle d'activité médico-chirurgicale cardiovasculaire, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Cardiovascular Research
|April 20, 2012
Summary
Recent advancements offer new treatments for lethal reperfusion injury, improving outcomes for myocardial infarction patients. Clinical trials show promise for drugs like cyclosporin in preventing irreversible heart damage.
Area of Science:
- Cardiology
- Pharmacology
- Experimental Medicine
Background:
- Lethal reperfusion injury is a significant cause of irreversible myocardial damage after heart attack.
- Ischaemic post-conditioning in animal models confirmed the importance of this post-reflow damage.
- Clinical translation of treatments has been challenging due to assessment complexities.
Purpose of the Study:
- To review the recent progress in treating lethal reperfusion injury.
- To highlight effective pharmacological agents and ongoing clinical trials.
- To discuss future directions for improving patient prognosis in ST-segment elevation myocardial infarction.
Main Methods:
- Review of clinical trials and experimental evidence on reperfusion injury.
- Analysis of pharmacological interventions and their efficacy.
- Discussion of technical challenges in assessing infarct size and area at risk.
Main Results:
- Cyclosporin and exenatide have shown significant benefit in alleviating lethal reperfusion injury.
- Erythropoietin and adenosine have not proven efficient.
- Ongoing clinical outcome studies are evaluating cyclosporin's effectiveness.
Conclusions:
- Pharmacological interventions represent a new era in managing myocardial infarction.
- Targeting lethal reperfusion injury can improve prognosis for ST-segment elevation myocardial infarction patients.
- Further research and clinical trials are needed to identify and test new agents.
Related Concept Videos
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...